Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skin

Experimental Dermatology

Volumn 24, Issue 10, 2015, Pages 723-726

  Gouin, Olivier ^a,b   Lebonvallet, Nicolas ^a   L'Herondelle, Killian ^a   Le Gall Ianotto, Christelle ^a   Buhé, Virginie ^a   Plée Gautier, Emmanuelle ^a   Carré, Jean Luc ^a   Lefeuvre, Luc ^b   Misery, Laurent ^a  

^a Laboratory of Neurosciences of Brest EA4685 University of Western Brittany   (France)

^b Dermatological Laboratories of Uriage   (France)

Author keywords

PAR; Inflammation; Mrgpr; Neurogenic; Neurotransmitter; Skin

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MAS RELEATED G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; UNCLASSIFIED DRUG; PROTEASE-ACTIVATED RECEPTOR 4; THROMBIN RECEPTOR;

ARTICLE; CUTANEOUS NEUROGENIC INFLAMMATION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOCOMPETENT CELL; NEUROGENIC INFLAMMATION; PROTEIN SYNTHESIS; PRURITUS; SENSORY NERVE; SKIN CELL; SKIN DISEASE; SKIN MANIFESTATION; ANIMAL; COMPLICATION; IMMUNITY; METABOLISM; PATHOPHYSIOLOGY; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES;

ANIMALS; HUMANS; IMMUNE SYSTEM PROCESSES; NEUROGENIC INFLAMMATION; RECEPTOR, PAR-2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, THROMBIN; SENSORY RECEPTOR CELLS; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES;

EID: 84942296789     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12798     Document Type: Article

References (75)

1. Koivisto A et al. Basic Clin Pharmacol Toxicol 2014: 114: 50-55.
2. Lembeck F, Holzer P. Naunyn Schmiedebergs Arch Pharmacol 1979: 310: 175-183.
3. Herbert M. K., Holzer P. Anästhesiol. Intensivmed. Notfallmedizin Schmerzther 2002: 37, 314-325.
4. Boillat A, Alijevic O, Kellenberger S. Mol Cell Neurosci 2014: 61C: 13-22.
5. Wei T et al. J Neuroinflammation 2012: 9: 181.
6. Dallos A et al. Neuropeptides 2006: 40: 251-263.
7. Chéret J., Lebonvallet N.Carré J.-L. et al. Wound Repair Regen 2013. 21, 772-788.
8. Pertovaara A, Koivisto A. Eur J Pharmacol 2011: 666: 1-4.
9. Pereira U et al. Exp Dermatol 2010: 19: 931-935.
10. Pereira U et al. Exp Dermatol 2010: 19: 796-799.
11. Bayliss W M. J Physiol 1901: 26: 173-209.
12. Liu X-Y et al. Mol Pain 2014: 10: 4.
13. Holzer P. Pharmacol Rev 1991: 43: 143-201.
14. Riol-Blanco L et al. Nature 2014: 510: 157-161.
15. Xanthos D N, Sandkühler J. Nat Rev Neurosci 2014: 15: 43-53.
16. Wilson S R et al. Cell 2013: 155: 285-295.
17. Dall'acqua M. C. et al. Life Sci 2014: 105; 7-13.
18. Huang L-Y M, Neher E. Neuron 1996: 17: 135-145.
19. Zhao P, Metcalf M, Bunnett N W. Front Endocrinol 2014: 5: 67.
20. Chen Y, Yang C, Wang Z J. Neuroscience 2011: 193: 440-451.
21. Steinhoff M et al. J Neurosci Off J Soc Neurosci 2003: 23: 6176-6180.
22. Fu Q et al. Inflammation 2014: 38: 886-895.
23. Graham D M, Huang L, Robinson K R et al. J Cell Sci 2013: 126: 4602-4613.
24. Straub R H. J Mol Med Berl Ger 2014: 92: 925-937.
25. Usuda H et al. J Pharmacol Sci 2012: 118: 266-274.
26. Andreev Y A, Vassilevski A A, Kozlov S A. Recent Pat Inflamm Allergy Drug Discov 2012: 6: 35-45.
27. Wilson S. R., Bautista D. M.In Itch: Mechanisms and Treatment (eds. Carstens E., Akiyama T., (CRC Press, 2014). at http://www.ncbi.nlm.nih.gov/books/NBK200927/
28. Cho S I et al. Acta Derm Venereol 2014: 95: 20-24.
29. Zygmunt P M, Högestätt E D. Handb Exp Pharmacol 2014: 222: 583-630.
30. Atoyan R, Shander D, Botchkareva N V. J Invest Dermatol 2009: 129: 2312-2315.
31. Vellani V et al. Mol Pain 2010: 6: 61.
32. McNeil B., Dong X. In Itch: Mechanisms and Treatment (eds. Carstens E., Akiyama T., ) (CRC Press, 2014). at http://www.ncbi.nlm.nih.gov/books/NBK200929/
33. Wilson S R et al. Nat Neurosci 2011: 14: 595-602.
34. Briot A et al. J Exp Med 2009: 206: 1135-1147.
35. Mollanazar N K, Smith P K, Yosipovitch G. Clin Rev Allergy Immunol 2015: 49: 1983-2015.
36. Tourdot B E et al. Arterioscler Thromb Vasc Biol 2014: 34: 2644-2650.
37. Houle S, Papez M D, Ferazzini M et al. Br J Pharmacol 2005: 146: 670-678.
38. Asfaha S et al. Br J Pharmacol 2007: 150: 176-185.
39. Karanjia R, Spreadbury I, Bautista-Cruz F et al. Neurogastroenterol Motil 2009: 21: 1218-1221.
40. Zhao P et al. J Biol Chem 2014: 289: 27215-27234.
41. Harvima I. T., Nilsson G., Naukkarinen A.G Ital Dermatol Venereol 2010: 145: 195-204.
42. D'Andrea M R et al. J Histochem Cytochem 1998: 46: 157-164.
43. Kempkes C., Buddenkotte J. et al. In Itch: Mechanisms and Treatment (eds. Carstens E., Akiyama T.) (CRC Press, 2014). at http://www.ncbi.nlm.nih.gov/books/NBK200911/
44. Steinhoff M et al. Nat Med 2000: 6: 151-158.
45. Russell F A, Veldhoen V E, Tchitchkan D et al. J Neurophysiol 2010: 103: 155-163.
46. Mascia F, Mariani V, Giannetti A et al. J Allergy Clin Immunol 2002: 109: 532-538.
47. Wang Z et al. J Neurosci Res 2013: 91: 1551-1562.
48. Zhu W-J et al. Brain Res 2005: 1041: 205-211.
49. Liu B, Zhang C, Qin F. J Neurosci Off J Soc Neurosci. 2005: 25: 4835-4843.
50. Liu Q., et al. Sci Signal 2011: 4: ra45.
51. Roosterman D, Goerge T, Schneider S W et al. Physiol Rev 2006: 86: 1309-1379.
52. Rickard A, Portell C, Kell P J et al. Am J Physiol Renal Physiol 2005: 288: F714-F721.
53. Ishikawa C, Tsuda T, Konishi H et al. Antimicrob Agents Chemother 2009: 53: 1760-1765.
54. Briot A et al. J Invest Dermatol 2010: 130: 2736-2742.
55. Shpacovitch V M et al. J Invest Dermatol 2002: 118: 380-385.
56. Megyeri M et al. J Immunol Baltim Md 2009: 1950: 3409-3416.
57. Wang Z et al. Neurochem Res 2013: 38: 1895-1903.
58. Chen D, Wang Z, Zhang Z et al. Cell Mol Neurobiol 2013: 33: 337-346.
59. Arachiche A, de la Fuente M, Nieman M T. PLoS ONE 2013: 8: e55740.
60. Buddenkotte J et al. J Invest Dermatol 2005: 124: 38-45.
61. Enjoji S., Ohama T. & Sato K.J Vet Med Sci Jpn Soc Vet Sci 2014: 76: 1225-1229.
62. Solinski H J, Gudermann T, Breit A. Pharmacol Rev 2014: 66: 570-597.
63. Dong X, Han S, Zylka M J et al. Cell 2001: 106: 619-632.
64. Liu Q et al. Cell 2009: 139: 1353-1365.
65. Akiyama T, Tominaga M, Takamori K et al. J Neurophysiol 2014: 112: 2283-2289.
66. Qu L et al. Brain J Neurol 2014: 137: 1039-1050.
67. Han L et al. Nat Neurosci 2013: 16: 174-182.
68. Bader M, Alenina N, Andrade-Navarro M A et al. Pharmacol Rev 2014: 66: 1080-1105.
69. Solinski H J et al. PLoS ONE 2013: 8: e58756.
70. Spicarova D, Adamek P, Kalynovska N et al. Neuropharmacology 2014: 81: 75-84.
71. Kulka M, Sheen C H, Tancowny B P et al. Immunology 2008: 123: 398-410.
72. Furio L et al. J Exp Med 2014: 211: 499-513.
73. Hovnanian A. Cell Tissue Res 2013: 351: 289-300.
74. Mijouin L et al. PLoS ONE 2013: 8: e78773.
75. Lee Y B et al. Ann Dermatol 2014: 26: 221-230.